Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Bharat Parenterals Ltd - 541096 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant to SEBI Circular no. CIR/CFD/CMD1/27/2019 dated February 8, 2019, read with Exchange Circular no. 20230316-14 dated March 16, 2023, please find enclosed herewith the Annual Secretarial Compliance Report of the Company issued by M/s Jigar Trivedi & Co., Practicing Company Secretaries of the Company for the financial year ended 31st March, 2023. We request you to kindly take the same on record.
30-05-2023
Bigul

Bharat Parenterals Ltd - 541096 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Extracts of the newspaper publications published in Business Standard and Loksatta Jansattta on 22nd May, 2023, relating to the Audited Standalone and Consolidated Financial Results for the for the quarter and year ended on 31st March, 2023. Request you to please take the same on record.
23-05-2023
Bigul

Bharat Parenterals Ltd - 541096 - Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Audited Financial Results For The Quarter And Year Ended On 31St March, 2023

 In compliance of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in its meeting held on 20th May, 2023, has considered and approved the Audited Financial Results for the Quarter and year ended 31st March, 2023 and taken on record Limited Review Report issued by the Statutory Auditors of the Company. The Board has also recommended payment of final dividend of Rs. 0.75 (Rupees Seventy-Five Paise Only) per Equity Share of Rs. 10/- each (fully paid-up) for the financial year ended March 31, 2023 and the same shall be payable subject to approval of the Shareholders at the ensuing Annual General Meeting ('AGM') of the Company.
20-05-2023
Bigul

Annual report for Bharat Parenterals Ltd. for FY-2023
20-05-2023
Bigul

Bharat Parenterals Ltd - 541096 - Update on board meeting

 Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2023 ,inter alia, to consider and approve Update on board meeting
19-05-2023
Bigul

Bharat Parenterals Ltd - 541096 - Board Meeting Intimation for Intimation Of Meeting Of Board Of Directors For Approval Of Audited Financial Results For The Quarter And Year Ended 31St March, 2023.

 Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2023 ,inter alia, to consider and approve we would like to inform you that in terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the meeting of Board of Directors of the Company is scheduled to be held on 20th May, 2023 at the registered office of the Company situated at Survey No. 144-A, Jarod Samlaya road, Village Haripura., Ta. Savli, Vadodara-391520, to consider and approve: 1. The Audited financial results of the Company for the Quarter and year ended on March 31st, 2023.
06-05-2023
Bigul

Bharat Parenterals Ltd - 541096 - Certificate Under Regulation 40(9) & (10) Of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015, For The Year Ended 31St March, 2023

 Enclose herewith Certificate under Regulation 40(9) & (10) of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015, for the year ended 31st March, 2023 issued by CS Niraj Trivedi, Practicing Company Secretary, Vadodara. We request you to kindly take the same on record.
25-04-2023
Bigul

Bharat Parenterals Ltd - 541096 - Compliance Certificate - Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015. For The Period Ended 31St March, 2023.

 Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained during the period April 01, 2022 to March 31, 2023 (both days inclusive) by the Company''s Registrar and Share Transfer Agent,viz., Adroit Corporate Services Private Limited, which is registered as Registrar & Share Transfer Agent in Category-I with the Securities and Exchange Board of India vide Registration Number: INR000002227. We request you to kindly take note of the above in your records.
12-04-2023
Bigul

Bharat Parenterals Ltd - 541096 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 The Confirmation Certificate pursuant to provisions of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 duly sent and confirmed by Adroit Corporate Services Private Limited viz., Company's Registrar and Share Transfer Agent, registered with Securities and Exchange Board of India for the period ended on 31st March, 2023. We request you to kindly take the same on record.
12-04-2023
Bigul

Bharat Parenterals Ltd - 541096 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

 Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Bharat Parenterals Ltd 2 CIN NO. L24231GJ1992PLC018237 3 Report filed for FY 2022-2023 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* NA 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) NA 8Quantum of (d), which has been met from (c)(e)* NA 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* NA Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)NA Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Shyam Singh RajpurohitDesignation :-Company Secretary Name of the Chief Financial Officer :- Jignesh Shah Designation : -CFO Date: 11/04/2023
11-04-2023
Next Page
Close

Let's Open Free Demat Account